inter-laboratory comparisons of dna and rna …abstract conclusions inter-laboratory comparisons of...
TRANSCRIPT
-
Abstract
Conclusions
Inter-Laboratory Comparisons of DNA and RNA Quality Assessment
Joanna Kerley-Hamilton 1, Stuart Levine 2, Charles Nicolet 3, Chris Wright 4, Savita Shanker 5, Jyothi Thimmapuram 6, Robert Lyons 7, Ariel Paulson 8, Anoja Perera 8, Marie Adams 9
1. Geisel School of Medicine at Dartmouth, 2. Mass. Inst. of Technology , 3. Univ. of Southern California , 4. Univ of Illinois, 5. Univ. of Florida, 6. Purdue Univ. , 7. Univ. of Michigan, 8. Stowers Inst. for Medical Research, 9. Univ. of Wisconsin
Survey Results
Experimental Design
Figure 1: Survey Results: The survey was sent to the entire ABRF mailing list, and completed by 44 individuals representing a variety of laboratories. Academic Core facilities represented almost 80% of respondents with the majority of those in mid sized facilities.
Quantifying RNA and DNA samples is one of the most basic methods used in all sequencing and microarray labs. A broad spectrum of instruments and techniques are used to ascertain nucleic acid quantity and quality, in preparation for more sophisticated analyses. Each laboratory tends to favor specific methods. However, beyond the manufacturer’s specifications, there are few standards to indicate how the instruments are performing relative to their optimal behavior, nor are there easy methods to directly compare platforms to examine relative benefits versus costs. The DSRG has surveyed over 40 core facilities to identify what equipment is currently being used. We have also directly measured the inter-lab reproducibility and inter- platform reproducibility of different DNA/RNA analyzers as well as their dynamic range using both RNA and DNA standards. Our updated results show that the Agilent BioAnalyzer 2100 remains the standard in the field, with the large majority of participating labs using the instrument at least once a week while newer instruments, such as the Agilent TapeStation and AATI Fragment Analyzer, are much less common among survey participants.
Quantitative methods are generally reproducible between labs and have modest variability (+/- 30%)
Analytical methods show poor quantification performance, have broad inter-lab variability, and modest reproducibility.
+/-20% specification is very difficult to achieve There was difficulty measuring accurately below
100pg/ul with all assays used.
Inter-Lab Experimental Results
Figure 5: IntraLab Variability. The data points within a lab are largely consistent within the range of each instrument suggesting that the serial dilutions were performed well. There is often a 2-4x difference seen between instruments. Each color represents a different QC method.
Figure 3: Dynamic Range for Analytical and Quantitative Methods. The range of concentrations that users perceive can be measured with each instrument varies widely and is often outside of the manufacturer’s supported range. The y-axis shows concentration and the width of the bar represents the number of respondents. Shaded boxes are the manufacturer’s supported range for analysis.
Figure 2: Instrument Usage for Analytical and Quantitative Methods: Survey results suggest that the bioanalyzerremains the most used analytical method. Nanodrop and Qubitare the predominant quantitative methods, with both pico- and ribo-green also widely used. This data suggests that labs are using multiple quantitation methods for sample QC.
Figure 4: Experimental DesignTwo DNA samples and 2 RNA samples were sent to 14 participating laboratories. Instructions were provided for performing serial dilutions and then measuring the quantity and quality of the samples on various quantitative and analytical instrumentation. Data was compiled by the DSRG.
DNA ‐ A
DNA ‐ B
RNA ‐ A
RNA ‐ B
NEB 50bp Ladder
Genomic Smear
High Quality RNA
Degraded RNA
Serial Dilute Samples (1:4)
Load on Mul ple Machines
Send Data to DSRG WORKSHEET Please create one worksheet per method.
METHOD DILUENT LAB DATE
Dilutiontotal mass 500bp mass 500bp size Det? total mass length of the peak Det? total mass RIN Det? total mass RIN Det?
12345678
DA (ladder) DB (smear) RA ‐ high quality RNA RB ‐ degraded RNA
comments/observations comments/observations comments/observations comments/observations
35
3 2 1 1
1 1 Academic core facility
Industry lab
Industry core facility
Academic lab
Diagnos c, academic and core facility
Government Core/Research
Hospital core facility
7
14 13
10 1 to 2 people
3 to 5 people
6 to 10 people
11+ people n=44
0 5 10 15 20 25 30 35 40 45
0 5
10 15 20 25 30 35 40 45
BioA
nalyzer
AATI
Fragm
ent
Analyzer
Calip
er Lab
Chip
Agile
nt Tap
e Sta
on
BioR
ad Exp
erion
Nan
odrop
Qub
it
RIBO
gree
n
Spec
trop
hotometer
Gem
ini Never
rarely
Monthly
Weekly
Daily
Mul ple mes per day
RNA
DNA
n=44
LAB1
Log(2)ob
served
/exp
ected LAB3 LAB2
Table 1: Participating Labs and Techniques Investigated. The participating labs provided data from at least 2 methods to be included in the study. The measured data was transformed to generate a factored concentration (ng/ul) based on the original dilution and then a LOG(2) value was used to generate the figures that are presented on this poster.
100
25
6.4
1.6
0.4
0.1
Measured length of 500bp band
ng loaded
BioA Frag.An. TapeStn
100
25
6.4
1.6
0.4
0.1
0.06
0.025
ng loaded
BioA Frag.An. TapeStn
RA RB
> >
Figure 6 (above): Variability Between Laboratories in both Quantitative and Analytical Methods. Data are represented for the Nanodrop, Qubit and Bioanalyzer, which are the 3 instruments with the most usage of the labs surveyed. The line graphs represent the variability of sample measurements for DNA samples, DA (light blue), and DB (dark blue), and for RNA samples, RA (light red) and RB (dark red). Box and Whisker plots are shown for the DA (50bp ladder) and RA (high quality RNA) only to show the intralabvariability.
Figure 9: RNA Quality. RNA Integrity Number (RIN) is a measure of RNA quality. Newer instruments tend to underestimate RIN scores. The BioAnalyzer pico kits also generate lower RIN scores.
Figure 8: Sizing of DNA. Data was reported from the analytical methods for the size of the 500bp band in sample DA (50bp ladder). The data shows that the Bio-Analyzer tends to underestimate size, compared with an overestimation for the newer instruments.
Agilent BioAnalyzer
Qubit
Nanodrop
$
AATI$Frag.An.$
Qubit$
Nanodrop$
n=35$ n=4$ n=21$ n=23$
BioAnalyzer$
10 1 100 10 1 100 10 1
pg /ul
ng/ul
ug/ul BioAnalyzer
n=37 n=5 n=26 n=29
AATI Frag.An.
Qubit
Nanodrop
DNA RNA
Caliper LabChip Agilent Tape Sta on AATI Fragment Analyzer
1
2
3
4
5
6
7
8
9
‐4
‐3
‐2
‐1
0
1
2
3
4
Nanodrop DA
100 25 6.4 1.6 0.4 0.1
1
2
3
4
5
6
7
8
9
‐4
‐3
‐2
‐1
0
1
2
3
4
Qubit DA
100 25 6.4 1.6 0.4 0.1
100 25 6.4 1.6 0.4 0.1
1
2
3
4
5
6
7
8
9
‐4
‐3
‐2
‐1
0
1
2
3
4
Nanodrop RA
100 25 6.4 1.6 0.4 0.1
1
2
3
4
5
6
7
8
9
‐4
‐3
‐2
‐1
0
1
2
3
4
Qubit RA
100 25 6.4 1.6 0.4 0.1
1
2
3
4
5
6
7
8
9
‐4
‐3
‐2
‐1
0
1
2
3
4
Bioanalyzer RA
100 25 6.4 1.6 0.4 0.1
DNA RNA
Figure 7 (left): Instrumentation with Limited Data. Data is shown for the Fragment Analyzer, Agilent Tape Station and Caliper LabChip instruments, which are some of the newer analytical methods available. Newer Caliper data is much more similar to AATI and BioAnalyzer data. Variability in RNA concentration is higher than for DNA samples in the analytical methods.
ng/ul
ng/ulng/ul
BioA AA TapeSt Caliper Nano QubitQuantiFluor RNaseP
A X XB X X XC X X X XD X X X XE XF X XG X X X XH X XI X X XJ X XK X XL X X X XM X X XN X X X X
Analytical & Quantitative Quantitative Only
100 25 6.4 1.6 0.4 0.1
Sample DA+B
0.025 100 25 6.4 1.6 0.4 0.1 0.0060.025
Sample DA+B
100 25 6.4 1.6 0.4 0.1 0.025
Sample RA+B
Sample DA+B
Sample RA+B
100 25 6.4 1.6 0.4 0.1 0.025
100 25 6.4 1.6 0.4 0.1 0.025 100 25 6.4 1.6 0.4 0.1 0.025
Sample DA+B
100 25 6.4 1.6 0.4 0.1 0.025
Sample RA+B
100 25 6.4 1.6 0.4 0.1 0.025
100 25 6.4 1.6 0.4 0.1 0.025ng/ul
100 25 6.4 1.6 0.4 0.1 0.025
ng/ul100 25 6.4 1.6 0.4 0.1 0.025
ng/ul100 25 6.4 1.6 0.4 0.1 0.025